Skippy Peanut Butter Recall Issued Over Steel Fragment Contamination

The recall affects 9,000 cases sold nationwide which may contain fragments from a piece of manufacturing equipment.

Nearly 200,000 pounds of Skippy peanut butter are being recalled due to a risk that stainless steel metal fragments may have contaminated products sold throughout the United States.

The U.S. Food and Drug Administration (FDA) announced the Skippy peanut butter recall on March 30, after an internal detection system determined that peanut butter jars distributed to retailers in at least 18 states may contain fragments from a piece of manufacturing equipment.

Although no reports of injuries have been received so far by the FDA or the manufacturer, Skippy Foods, LLC, ingesting small metal fragments could result in serious and potentially life-threatening intestinal injuries.

The recalled peanut butter is known to have been sold by retailers in California, Connecticut, Delaware, Florida, Hawaii, Illinois, Indiana, Kansas, Massachusetts, Minnesota, Missouri, North Carolina, Nebraska, New Hampshire, New Jersey, New York, Oklahoma, and Wisconsin. However, it is possible the contaminated peanut butter was distributed in other states.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall includes 40 oz jars of Skippy Reduced Fat Creamy Peanut Butter, with Best if Used By dates of MAY0423 and MAY0523; packs of two 40 oz jars of Skippy Reduced Fat Creamy Peanut Butter, with Best if Used By dates of MAY0523, 16.3 oz jars of Skippy Reduced Fat Chunky Peanut Butter, with Best if Used By dates of MAY0623 and MAY0723; and 14 oz jars of Skippy Creamy Peanut Butter Blended With Plant Protein, with Best if Used By dates mf MAY1023.

A step-by-step guide to help consumers determine if they have a product that is part of the recall can be found on the Skippy website.

If you believe you may own or have come into contact with this product, the FDA suggests that you return it to your retailer for an exchange or call Skippy Foods Consumer Engagement at 1-866-475-4779. You can also visit the manufacturer’s website for additional instructions and information.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.